FSB Premier Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$302K Sell
10,751
-518
-5% -$13.8K 0.09% 193
2025
Q4
$281K Buy
11,269
+58
+0.5% +$1.46K 0.09% 196
2025
Q3
$286K Buy
11,211
+1,690
+18% +$41.7K 0.09% 188
2025
Q2
$231K Sell
9,521
-120
-1% -$2.8K 0.08% 198
2025
Q1
$244K Sell
9,641
-830
-8% -$21.7K 0.1% 189
2024
Q4
$278K Sell
10,471
-131
-1% -$3.55K 0.11% 175
2024
Q3
$307K Sell
10,602
-1,015
-9% -$29.6K 0.13% 163
2024
Q2
$325K Buy
11,617
+116
+1% +$3.19K 0.15% 139
2024
Q1
$319K Buy
11,501
+2,305
+25% +$64K 0.15% 135
2023
Q4
$265K Sell
9,196
-651
-7% -$19.7K 0.13% 139
2023
Q3
$327K Buy
9,847
+371
+4% +$13.1K 0.18% 106
2023
Q2
$348K Buy
9,476
+91
+1% +$3.54K 0.19% 103
2023
Q1
$383K Buy
9,385
+1,916
+26% +$82.8K 0.21% 93
2022
Q4
$383K Buy
7,469
+150
+2% +$7.19K 0.21% 94
2022
Q3
$320K Buy
7,319
+23
+0.3% +$1.12K 0.19% 105
2022
Q2
$382K Buy
7,296
+161
+2% +$8.2K 0.21% 93
2022
Q1
$360K Sell
7,135
-1,163
-14% -$60.3K 0.18% 99
2021
Q4
$490K Sell
8,298
-1,151
-12% -$57K 0.2% 86
2021
Q3
$406K Sell
9,449
-1,026
-10% -$45.5K 0.2% 78
2021
Q2
$410K Buy
10,475
+921
+10% +$35.8K 0.21% 73
2021
Q1
$346K Buy
9,554
+175
+2% +$6.21K 0.19% 77
2020
Q4
$345K Buy
+9,379
New +$344K 0.18% 78

Other funds holding PFE

FSB Premier Wealth Management's PFE Position: Q1 2026 in Review

FSB Premier Wealth Management reduced its Pfizer (PFE) stake by 4.6% in Q1 2026, selling an estimated $13.8K and leaving 10,751 shares worth $302K. The position accounts for 0.09% of the portfolio, ranked #193.

FSB Premier Wealth Management first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $490K in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • FSB Premier Wealth Management held 10,751 shares of Pfizer worth $302K as of Q1 2026.
  • FSB Premier Wealth Management sold 518 Pfizer shares in Q1 2026, an estimated $13.8K.
  • Pfizer made up 0.09% of FSB Premier Wealth Management's portfolio in Q1 2026, its #193 holding.
  • FSB Premier Wealth Management first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • FSB Premier Wealth Management's Pfizer position peaked at $490K in Q4 2021.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on FSB Premier Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.